Zimmer Biomet Holdings Inc logo

ZBH

Zimmer Biomet Holdings Inc

$113.35

Earnings Summary

Revenue
$1781.8Mn
Net Profits
$154Mn
Net Profit Margins
8.64%
PE Ratio
65

Highlights

Revenue:

Zimmer Biomet Holdings Inc’s revenue fell -12.09% since last year same period to $1781.8Mn in the Q2 2022. On a quarterly growth basis, Zimmer Biomet Holdings Inc has generated 7.13% jump in its revenue since last 3-months.

Net Profits:

Zimmer Biomet Holdings Inc’s net profit jumped 8.53% since last year same period to $154Mn in the Q2 2022. On a quarterly growth basis, Zimmer Biomet Holdings Inc has generated 984.51% jump in its net profits since last 3-months.

Net Profit Margins:

Zimmer Biomet Holdings Inc’s net profit margin jumped 23.46% since last year same period to 8.64% in the Q2 2022. On a quarterly growth basis, Zimmer Biomet Holdings Inc has generated 912.32% jump in its net profit margins since last 3-months.

PE Ratio:

Zimmer Biomet Holdings Inc’s price-to-earnings ratio after this Q2 2022 earnings stands at 65.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Zimmer Biomet Holdings Inc post its latest quarter earnings

EPS Estimate Current Quarter
1.65
EPS Estimate Current Year
1.65

Highlights

EPS Estimate Current Quarter:

Zimmer Biomet Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at 1.65 - a 17.02% jump from last quarter’s estimates.

EPS Estimate Current Year:

Zimmer Biomet Holdings Inc’s earning per share (EPS) estimates for the current year stand at 1.65.

Key Ratios

Key ratios of the Zimmer Biomet Holdings Inc post its Q2 2022 earnings

Earning Per Share (EPS)
1.82
Return on Assets (ROA)
0.03
Return on Equity (ROE)
0.03
Dividend Per Share (DPS)
0.96

Highlights

Earning Per Share (EPS):

Zimmer Biomet Holdings Inc’s earning per share (EPS) fell -4.21% since last year same period to 1.82 in the Q2 2022. This indicates that the Zimmer Biomet Holdings Inc has generated -4.21% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Zimmer Biomet Holdings Inc’s return on assets (ROA) stands at 0.03.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Zimmer Biomet Holdings Inc’s return on equity (ROE) stands at 0.03.

Dividend Per Share (DPS):

Zimmer Biomet Holdings Inc declared 0.96 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-08-02
1.65
1.82
10.3%
2022-05-05
1.41
1.61
14.18%

Company Information

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

Organisation
Zimmer Biomet Holdings Inc
Headquarters
345 East Main Street, Warsaw, IN, United States, 46580
Employees
20000
Industry
Health Technology
CEO
Bryan Hanson